SciVision Biotech Inc (1786) — Strategic Asset Allocation Index
SciVision Biotech Inc (1786) has a Strategic Asset Allocation Index of 78.4% as of December 2022. Strategic assets (PP&E of NT$1.18 Billion plus long-term investments of NT$-) total NT$1.18 Billion, measured against net assets of NT$1.51 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
SciVision Biotech Inc Strategic Asset Allocation Index (2015–2022)
This chart shows how SciVision Biotech Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of December 2022, the index stands at 78.4%, representing strategic assets of NT$1.18 Billion against net assets of NT$1.51 Billion TWD. Explore 1786 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for SciVision Biotech Inc (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for SciVision Biotech Inc from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of SciVision Biotech Inc.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 78.4% | NT$1.18 Billion | NT$1.18 Billion | NT$- | NT$1.51 Billion | ▼ -7.5 pp |
| 2021 | 85.9% | NT$1.25 Billion | NT$1.25 Billion | NT$- | NT$1.45 Billion | ▼ -6.4 pp |
| 2020 | 92.3% | NT$1.30 Billion | NT$1.30 Billion | NT$- | NT$1.40 Billion | ▼ -0.9 pp |
| 2019 | 93.2% | NT$1.27 Billion | NT$1.27 Billion | NT$2.00 Million | NT$1.36 Billion | ▼ -7.2 pp |
| 2018 | 100.4% | NT$1.08 Billion | NT$1.08 Billion | NT$- | NT$1.08 Billion | ▼ -10.6 pp |
| 2017 | 111.0% | NT$1.02 Billion | NT$1.01 Billion | NT$6.83 Million | NT$914.45 Million | ▲ +35.9 pp |
| 2016 | 75.1% | NT$671.16 Million | NT$656.16 Million | NT$15.00 Million | NT$894.21 Million | ▲ +31.1 pp |
| 2015 | 43.9% | NT$416.83 Million | NT$401.83 Million | NT$15.00 Million | NT$948.60 Million | — |